BLRX
BioLineRX
BLRX
BLRX
29 hedge funds and large institutions have $1.49M invested in BioLineRX in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
30% less capital invested
Capital invested by funds: $2.12M → $1.49M (-$639K)
85% less call options, than puts
Call options by funds: $33K | Put options by funds: $223K
Holders
29
Holding in Top 10
–
Calls
$33K
Puts
$223K
Top Buyers
| 1 | +$170K | |
| 2 | +$83.9K | |
| 3 | +$35.3K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$26.3K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$19.3K |
Top Sellers
| 1 | -$207K | |
| 2 | -$48K | |
| 3 | -$38K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$36.1K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$29.8K |